PMC:7283670 / 48783-49546
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T170 | 132-138 | Body_part | denotes | Throat | http://purl.org/sig/ont/fma/fma228738 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T116 | 132-138 | Body_part | denotes | Throat | http://purl.obolibrary.org/obo/UBERON_0000341 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T292 | 189-197 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T488 | 89-91 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T489 | 101-105 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
| T490 | 101-105 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
| T491 | 707-708 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T492 | 749-754 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T142 | 101-105 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
| T143 | 534-543 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T144 | 564-575 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T145 | 755-763 | Chemical | denotes | carriers | http://purl.obolibrary.org/obo/CHEBI_78059 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T539 | 0-236 | Sentence | denotes | Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate |
| T540 | 237-336 | Sentence | denotes | Results: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation |
| T541 | 337-470 | Sentence | denotes | (after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: |
| T542 | 471-479 | Sentence | denotes | 3, both: |
| T543 | 480-509 | Sentence | denotes | 3 Symptom onset to recovery: |
| T544 | 510-588 | Sentence | denotes | 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr) |
| T545 | 589-637 | Sentence | denotes | Resolved clinical symptoms and CT abnormalities: |
| T546 | 638-639 | Sentence | denotes | 3 |
| T547 | 640-664 | Sentence | denotes | Delicate patches of GGO: |
| T548 | 665-666 | Sentence | denotes | 1 |
| T549 | 667-763 | Sentence | denotes | Interpretation: possibility of at least a proportion of recovered patients act as virus carriers |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T185 | 455-460 | Phenotype | denotes | Fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T186 | 464-469 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1182 | 733-741 | Species | denotes | patients | Tax:9606 |
| 1382 | 189-197 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 1383 | 455-460 | Disease | denotes | Fever | MESH:D005334 |
| 1384 | 464-469 | Disease | denotes | cough | MESH:D003371 |